The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made… Read More
News round-up for 4 – 8 May by Bruno Quinney, Content Team at DDW. This week, the FDA has advanced an initiative to implement real-time clinical trials. Elsewhere, UCB has made headlines for through an acquisition and its cancer research venture. The top stories: FDA moves… Read More
A previously undiscovered target for treating malaria could pave the way for a new generation of drugs, experts say. Researchers from the Universities of Bath and Leeds, UK have made a significant advance in the fight against malaria by uncovering a promising new potential target for drug discovery. … Read More
Researchers at the University of Bath, in collaboration with the Universities of Oxford and Bristol, have developed a molecule that prevents the clumping and build-up of alpha-synuclein, a protein linked to Parkinson’s disease and related dementias. The team has successfully demonstrated it works in an animal model… Read More
A new study has highlighted two new potential families of drug molecules that could open the door to new treatments for tuberculosis (TB). TB, caused by the bacterium Mycobacterium TB, is the second largest infectious killer globally after Covid-19 and causes 1.3 million deaths annually. … Read More
Scientists from the UK and South Africa have discovered a surprising new role for a commonly-used antibiotic that could open the door to a new family of improved therapies for high blood pressure and cardiovascular disease. The international team, led by Professor Ravi Acharya from the University… Read More
Reportedly for the first time, researchers from the University of Bath have identified promising drug candidates that bind irreversibly with a notoriously ‘undruggable’ cancer protein target, permanently blocking it. Transcription factors are proteins that act as ‘master switches’ of gene activity and play a key role in cancer… Read More
The UK’s Channel 4’s Dispatches: Skinny Jab Scandal investigational documentary has highlighted significant concerns about pharmaceutical giant Novo Nordisk’s promotional practices. Here, DDW outlines the case and provides comment from a Novo Nordisk spokesperson. The documentary featured expert insights from Dr Piotr Ozieranski and Dr Emily Rickard of the University… Read More
Action is needed to safeguard the independence of patient organisations and charities, according to the findings of a new study. The study by the University of Bath, UK, Lund University, Sweden and Kozminski University, Poland, concludes that patient organisations and charities across Europe are at risk of… Read More
Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. This new tool may help researchers develop new pharmaceuticals in a cleaner, greener, and less expensive way. Drug treatments often… Read More
Scientist, pharmaceutical entrepreneur and philanthropist Professor Raymond Schinazi has donated £2 ($2.5) million to establish the first Raymond Schinazi and Family Chair of Life Sciences at the University of Bath. The endowment will go towards the establishment of the new Department of Life Sciences, with the Department’s… Read More
